MannKind Corporation (MNKD) financial statements (2022 and earlier)

Company profile

Business Address 1 CASPER STREET
DANBURY, CT 06810
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments204675071442359
Cash and cash equivalents124673071442359
Short-term investments80 20    
Restricted cash and investments 0014  
Receivables5444300
Inventory, net of allowances, customer advances and progress billings754432 
Inventory754432 
Deferred costs    0014
Assets held-for-sale, not part of disposal group     17 
Other undisclosed current assets33333354
Total current assets:220796182577777
Noncurrent Assets
Property, plant and equipment37262726272949
Long-term investments and receivables57      
Long-term investments57      
Other noncurrent assets8360011
Total noncurrent assets:101293326273050
TOTAL ASSETS:3211099410885107126
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities34252120191124
Accounts payable76557316
Accrued liabilities272016151288
Deferred revenue13333
Debt7 511537175
Deferred revenue and credits33158
Contract with customer, liability37
Other undisclosed current liabilities6157712612
Total current liabilities:487466758892268
Noncurrent Liabilities
Long-term debt and lease obligation3196819242828
Long-term debt, excluding current maturities2245519242828
Finance lease, liability94  
Operating lease, liability113
Liabilities, other than long-term debt43657883805765
Deferred revenue2028
Contract with customer, liability11
Due to related parties18637072805050
Other liabilities5     15
Derivative instruments and hedges, liabilities     7 
Other undisclosed noncurrent liabilities121144133106108114116
Total noncurrent liabilities:482215219208212199208
Total liabilities:531289284283299291477
Stockholders' equity
Stockholders' equity attributable to parent(209)(180)(191)(175)(215)(184)(350)
Common stock3222154
Additional paid in capital2,9182,8662,7992,7632,6392,5492,509
Accumulated other comprehensive loss  (0)(0)(0)(0)(0)
Accumulated deficit(3,130)(3,049)(2,992)(2,940)(2,855)(2,738)(2,863)
Total stockholders' equity:(209)(180)(191)(175)(215)(184)(350)
TOTAL LIABILITIES AND EQUITY:3211099410885107126

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues7565632812175 
Revenue, net12175 
Cost of revenue(28)(30)(25)(19)(27)(38)(36)
Cost of goods and services sold(17)(15)(20)(19)(20)(17)(36)
Gross profit:4735388(15)137(36)
Operating expenses(94)(83)(83)(88)(93)(70)(345)
Other undisclosed operating income   3  36
Operating income (loss):(47)(48)(45)(77)(108)67(345)
Nonoperating income (expense)(34)(10)(7)(10)(9)581
Other nonoperating income (expense)(0)0(1)(0)0(1)1
Interest and debt expense(17)(0)4(0)(0)72(1)
Income (loss) from continuing operations before equity method investments, income taxes:(98)(58)(48)(87)(117)198(344)
Other undisclosed income (loss) from continuing operations before income taxes170(4)00(72)(24)
Income (loss) from continuing operations before income taxes:(81)(57)(52)(87)(117)126(368)
Income tax expense (benefit)2005(0)(0)  
Income (loss) before gain (loss) on sale of properties:(61)(57)(47)(87)(117)126(368)
Other undisclosed net loss(20) (5)    
Net income (loss) available to common stockholders, diluted:(81)(57)(52)(87)(117)126(368)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):(81)(57)(52)(87)(117)126(368)
Other comprehensive loss      (0)
Comprehensive income (loss):(81)(57)(52)(87)(117)126(368)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent (0) (0)0(0) 
Comprehensive income (loss), net of tax, attributable to parent:(81)(57)(52)(87)(117)126(368)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: